|
![]() |
Cardiovascular Health > Acute Myocardial Infarction (heart attack)
The following information is about Acute Myocardial Infarction (heart attack).
Acute Myocardial Infarction (heart attack) Defined
A blockage from the formation of a blood clot in one or more of the blood vessels to the heart. Damage to the heart muscle results, due to the lack of blood flow.
This definition is in context to Cardiovascular Health. See more contextual defintions for Acute Myocardial Infarction (heart attack).
Major Bleeding Has Significant Impact And Contributes To 30-Day Mortality Following Angioplasty In Severe Heart Attack ...
Published September 5, 2008, 4:16 am, Medical News Today
The Medicines Company (NASDAQ: MDCO) announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in severe heart attack patients treated with angioplasty.
The Role Played By Drug-Eluting Stents In Reducing Mortality In AMI
Published September 5, 2008, 3:15 am, Medical News Today
The safety debate about drug-eluting stents (DES) is still ongoing. In these times of uncertainty about DES safety, the study has shown that DES markedly improve long-term survival compared to modern bare-metal stents (BMS) implantation in patients with acute ST-segment elevation myocardial infarction (STEMI).
Positive Phase II Results For FX06 - Fibrin-Derived Peptide For The Treatment Of Reperfusion Injury In Myocardial ...
Published September 4, 2008, 7:11 am, Medical News Today
Fibrex Medical, a biopharmaceutical company focusing on cardiovascular and inflammatory diseases, announced positive Phase II results for FX06, a peptide for the treatment of reperfusion injury - the damage to heart muscle that results from remedial treatment following a heart attack. The results will be presented at the ESC Congress today in Munich, Germany.
miRagen Therapeutics, Inc. And Collaborators Publish Study Identifying microRNA Perturbations Following Acute ...
Published September 4, 2008, 7:09 am, Medical News Today
miRagen Therapeutics, Inc., a biopharmaceutical company focused on the discovery and development of breakthrough therapies for cardiovascular and muscle disease based on microRNA biology, today announced the publication of novel research demonstrating that acute myocardial infarction (MI) in mice and humans results in the dysregulation of a specific set of microRNAs.
Myocardial Regeneration By Intracoronary Infusion Of Selected Population Of Stem Cells In AM
Published September 4, 2008, 6:09 am, Medical News Today
REGENT is a multicenter, randomized trial for comparison of intracoronary infusion of bone marrow-derived unselected mononuclear cells (MNC) and selected CD34+CXCR4+ cells in 200 patients with acute myocardial infarction and reduced LVEF ≤ 40%. Primary end-point was change of LV ejection fraction (LVEF) and volumes measured by MRI before and 6 months after the procedure.
Prasugrel Significantly Reduced New Or Recurrent Heart Attacks In Both Acute And Longer-Term Settings Following PCI, ...
Published September 4, 2008, 3:10 am, Medical News Today
A sub-analysis of the TRITON-TIMI 38 clinical trial showed that treatment with prasugrel compared with clopidogrel significantly reduced the risk of new or recurrent heart attacks (7.4 percent vs. 9.
Prasugrel reduces cardiovascular events in diabetes patients by 40% compared to clopidogrel
Published September 4, 2008, 2:52 am, PharmaBiz
Patients who were diabetic and diagnosed with acute coronary syndromes (ACS) were 40 per cent less likely to suffer a heart attack if they were treated with prasugrel vs. clopidogrel, according to a sub-group analysis of the Triton-TIMI 38 trial (8.2 per cent vs. 13.2 per cent, P The diabetic sub-group analysis was presented by Stephen Wiviott, assistant Professor of Medicine at Harvard Medical ...
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality ...
Published September 3, 2008, 9:24 am, Centre Daily Times
The Medicines Company (NASDAQ:MDCO) today announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in severe heart attack patients treated with angioplasty. This analysis of ST-elevation myocardial infarction (STEMI) patients was presented at the European ...
New Analysis From HORIZONS-AMI Shows Major Bleeding Has a Significant Impact and Contributes to 30-Day Mortality ...
Published September 3, 2008, 9:00 am, Business Wire via Yahoo! Finance
PARSIPPANY, N.J.----The Medicines Company today announced the presentation of a new analysis of data from the HORIZONS-AMI trial demonstrating that major bleeding contributes to more deaths at 30 days than repeat heart attack, or re-infarction, in severe heart attack patients treated with angioplasty.
Medicure Inc.: New Data Shows AGGRASTAT Offers Significant Benefits to Patients with Poor Response to Aspirin and/or ...
Published September 3, 2008, 8:16 am, Marketwire via Yahoo! Finance
Medicure Inc., a cardiovascular focused, biopharmaceutical company, today announced that new data presented at the annual European Society of Cardiology Congress in Munich, Germany showed AGGRASTAT® significantly lowers the incidence of heart attack after elective coronary angioplasty in coronary artery disease patients who have shown poor response to standard oral antiplatelet agents, aspirin ...
Are you looking for additional Cardiovascular Health > Acute Myocardial Infarction (heart Attack) news? Try our new "Acute Myocardial Infarction (heart Attack) News Focus" area.
Social bookmarks are not available at the moment.
If you would like to find additional social bookmark based links on the topic of we recommend the Open Tag Directory > Acute Myocardial Infarction (heart attack). If you would like to find related tags we recommend Tag Patterns > Acute Myocardial Infarction (heart attack)
Off-site Acute Myocardial Infarction (heart Attack) Research Links
If you still need additional information on Acute Myocardial Infarction (heart Attack) then we suggest the following off-site resources. Please note, because these resources are off-site we cannot guarantee the accuracy or quality of any information.
- A9 > Acute Myocardial Infarction (heart attack)
- Alexa > Acute Myocardial Infarction (heart attack)
- Anti-Aging Revolution > Acute Myocardial Infarction (heart attack)
- DMOZ > Acute Myocardial Infarction (heart attack)
- Feeds Filtered > Acute Myocardial Infarction (heart attack)
- Google > Acute Myocardial Infarction (heart attack)
- News Meme > Acute Myocardial Infarction (heart attack)
- Nuah: News > Acute Myocardial Infarction (heart attack)
- The Feed Directory > Acute Myocardial Infarction (heart attack)
- OBP > Acute Myocardial Infarction (heart attack)
- Open Tag Directory > Acute Myocardial Infarction (heart attack)
- Podzy > Acute Myocardial Infarction (heart attack)
- Yahoo > Acute Myocardial Infarction (heart attack)
Cardiovascular Health Topics
Everything you need to know about Cardiovascular Health
Cardiovascular Health
If you know the Cardiovascular Health Term Name use the links below to quickly jump to your desired focus.
Bookmark Us
The On Topic Network
This website is part of The On Topic Network.
Thank You
Cardiovascular-Health.On-Topic.net was developed by Odin Metatech, Inc and runs on the Odin Assemble platform.
Best Viewed With
License
This work is licensed under Creative Commons.
